President Donald Trump, while hosting King Abdullah II of Jordan at the White House on Tuesday, continued to press a plan to ...

Each year, flu experts from around the world gather to map out recommendations for next winter's flu vaccine. This year, it's ...

HER2, a HER2-targeted immunotherapy, with plans for FDA submission following promising Phase 2b data in osteosarcoma.

NEW YORK - OS Therapies, Inc. (NYSE-A: OSTX), a small-cap biotech firm with a market capitalization of $42 million focusing on cancer treatment solutions, has announced the completion of its Phase 2b ...

Nearly 1,300 probationary employees at the CDC -- roughly one-tenth of the agency's workforce -- are being forced out under ...

Director General of the Faisalabad Development Authority (FDA) Muhammad Asif Chaudhry has said that Bhagat Singh's historic haveli, a treasured heritage site, would receive full government support for ...

Mesoblast Limited (Nasdaq:MESO; ASX:MSB), a global leader in allogeneic cellular medicines for inflammatory diseases, today ...

Travere Therapeutics aims to seek traditional approval based on data from the Phase 3 DUPLEX and Phase 2 DUET studies of FILSPARI, with submission expected by the end of the first quarter of 2025. The ...

PHILADELPHIA, Feb. 14, 2025 (GLOBE NEWSWIRE) -- Medicus Pharma Ltd. (NASDAQ: MDCX) ("Medicus" or the "Company") is also pleased to announce that its phase 2 clinical study (SKNJCT-003) which is ...

Karolinska Development AB (Nasdaq Stockholm: KDEV) today publishes its Year-end Report January-December 2024. The full report is available on the Company's website. "Stronger ...

Boca Raton, Florida Wednesday, February 12, 2025, 16:00 Hrs [IST] ...

Dr. Guru P Sonpavde discusses updated data from studies like EV-302 and CheckMate 274 for patients with urothelial cancer at ...